A closer look at rituximab induction on HLA antibody rebound following HLA incompatible kidney transplantation

Rituximab has been used to increase the efficacy of desensitization protocols for HLA incompatible kidney transplantation, however, controlled comparisons have not been reported. Here we examined 256 post-transplant HLA antibody levels in 25 recipients desensitized with or 25 without rituximab induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Annette M., Kraus, Edward S., Orandi, Babak J., Segev, Dorry L., Montgomery, Robert A., Zachary, Andrea A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305036/
https://www.ncbi.nlm.nih.gov/pubmed/25054778
http://dx.doi.org/10.1038/ki.2014.261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305036/
https://www.ncbi.nlm.nih.gov/pubmed/25054778
http://dx.doi.org/10.1038/ki.2014.261

Ejemplares similares